Effect of superficial cryotherapy versus intralesional Triamcinolone injection on Patchy Alopecia Areata of scalp
Phase 3
Not yet recruiting
- Conditions
- Alopecia areata.Alopecia areata
- Registration Number
- IRCT20120215009014N514
- Lead Sponsor
- Hamedan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Pending
- Sex
- All
- Target Recruitment
- 31
Inclusion Criteria
Age 18 to 60 years
Age 18 to 60 yearsPatchy Alopecia Areata of scalp
Exclusion Criteria
Pregnancy or breastfeeding
Involvement of other areas of the body such as eyebrows, eyelashes, beard and nails
Diabetes mellitus or thyroid disorder
History of cold urticaria or cold intolerance
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie the efficacy of superficial cryotherapy in treating patchy Alopecia Areata?
How does intralesional Triamcinolone injection compare to superficial cryotherapy in managing scalp Alopecia Areata?
Are there specific biomarkers that predict response to superficial cryotherapy or Triamcinolone in Alopecia Areata patients?
What are the potential adverse events associated with superficial cryotherapy versus intralesional Triamcinolone for Alopecia Areata?
What combination therapies or alternative treatments are being explored alongside superficial cryotherapy for Alopecia Areata?